Filing Details
- Accession Number:
- 0000899243-21-029437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-22 07:37:40
- Reporting Period:
- 2021-07-15
- Accepted Time:
- 2021-07-22 07:37:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783328 | Tscan Therapeutics Inc. | TCRX | Biological Products, (No Disgnostic Substances) (2836) | 825282075 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1860597 | M. Brian Silver | C/O Tscan Therapeutics, Inc. 830 Winter Street Waltham MA 02451 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2021-07-20 | 1,000 | $15.00 | 1,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents shares purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
